A randomised controlled crossover trial of biofeedback control of end-dialysis plasma conductivity versus progressive reduction of dialysate conductivity.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32121550

Enrollment

Registered

2005-09-30

Start date

2003-12-18

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological and Genital Diseases: Renal Urological and Genital Diseases Renal

Interventions

We propose to randomise patients to serial reduction of fixed dialysate conductivity or to reduction of end-dialysis plasma conductivity achieved using a biofeedback loop (Diacontrol). Diacontrol mon

Eligibility

Inclusion criteria

Inclusion criteria: Chronic haemodialysis patients

Exclusion criteria

Exclusion criteria: 1. > 2 episodes of hypotension/week on current dialysis 2. On HDF

Design outcomes

Primary

Measure	Time frame
1. End-dialysis plasma conductivity 2. Numbers of patients achieving each reduction 3. Haemodynamic stability, assessed using a variety of measures	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026